Endothelial CSN5 impairs NF-κB activation and monocyte adhesion to endothelial cells and is highly expressed in human atherosclerotic lesions.
about
Troxerutin protects against diabetic cardiomyopathy through NF‑κB/AKT/IRS1 in a rat model of type 2 diabetesApple Polyphenols Decrease Atherosclerosis and Hepatic Steatosis in ApoE-/- Mice through the ROS/MAPK/NF-κB PathwayOxidized LDL-induced JAB1 influences NF-κB independent inflammatory signaling in human macrophages during foam cell formation.Inhibition of atherogenesis by the COP9 signalosome subunit 5 in vivo.Therapeutic effects of fibroblast growth factor‑21 against atherosclerosis via the NF‑κB pathway.COP9 signalosome subunit CSN5, but not CSN6, is upregulated in lung adenocarcinoma and predicts poor prognosis.
P2860
Endothelial CSN5 impairs NF-κB activation and monocyte adhesion to endothelial cells and is highly expressed in human atherosclerotic lesions.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Endothelial CSN5 impairs NF-κB ...... human atherosclerotic lesions.
@en
Endothelial CSN5 impairs NF-κB ...... human atherosclerotic lesions.
@nl
type
label
Endothelial CSN5 impairs NF-κB ...... human atherosclerotic lesions.
@en
Endothelial CSN5 impairs NF-κB ...... human atherosclerotic lesions.
@nl
prefLabel
Endothelial CSN5 impairs NF-κB ...... human atherosclerotic lesions.
@en
Endothelial CSN5 impairs NF-κB ...... human atherosclerotic lesions.
@nl
P2093
P50
P356
P1476
Endothelial CSN5 impairs NF-κB ...... human atherosclerotic lesions.
@en
P2093
Anke K Schütz
Heidi Noels
Jürgen Bernhagen
Menno P J de Winther
Omar El Bounkari
P304
P356
10.1160/TH13-02-0155
P577
2013-05-02T00:00:00Z